What is B. Riley’s Estimate for Celsius FY2025 Earnings?

Celsius Holdings, Inc. (NASDAQ:CELHFree Report) – Research analysts at B. Riley upped their FY2025 earnings estimates for shares of Celsius in a research report issued on Wednesday, November 6th. B. Riley analyst J. Van. Sinderen now anticipates that the company will post earnings of $0.79 per share for the year, up from their prior estimate of $0.71. B. Riley currently has a “Buy” rating and a $47.00 target price on the stock. The consensus estimate for Celsius’ current full-year earnings is $0.70 per share.

A number of other research analysts also recently issued reports on CELH. Stifel Nicolaus dropped their price target on shares of Celsius from $51.00 to $45.00 and set a “buy” rating on the stock in a research report on Thursday, November 7th. TD Cowen dropped their target price on shares of Celsius from $68.00 to $50.00 and set a “buy” rating on the stock in a research report on Wednesday, August 7th. Jefferies Financial Group dropped their target price on shares of Celsius from $53.00 to $48.00 and set a “buy” rating on the stock in a research report on Thursday, October 10th. Roth Mkm dropped their target price on shares of Celsius from $43.00 to $40.00 and set a “buy” rating on the stock in a research report on Thursday, November 7th. Finally, Morgan Stanley reiterated an “equal weight” rating and set a $50.00 target price on shares of Celsius in a research report on Tuesday, August 20th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $54.40.

Read Our Latest Stock Report on CELH

Celsius Stock Performance

Shares of NASDAQ CELH opened at $27.39 on Monday. The company has a market capitalization of $6.44 billion, a P/E ratio of 38.04, a price-to-earnings-growth ratio of 2.52 and a beta of 1.86. Celsius has a 52-week low of $27.37 and a 52-week high of $99.62. The company’s 50 day moving average price is $32.15 and its 200-day moving average price is $50.92.

Insider Transactions at Celsius

In other news, CEO John Fieldly sold 74,847 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $32.80, for a total value of $2,454,981.60. Following the completion of the sale, the chief executive officer now owns 1,812,490 shares in the company, valued at $59,449,672. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 2.20% of the company’s stock.

Hedge Funds Weigh In On Celsius

Institutional investors have recently added to or reduced their stakes in the stock. S.A. Mason LLC purchased a new stake in Celsius during the second quarter valued at about $30,000. EverSource Wealth Advisors LLC lifted its holdings in shares of Celsius by 3,116.7% in the first quarter. EverSource Wealth Advisors LLC now owns 386 shares of the company’s stock worth $32,000 after buying an additional 374 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt purchased a new stake in shares of Celsius in the third quarter worth about $34,000. Signaturefd LLC lifted its holdings in shares of Celsius by 48.3% in the third quarter. Signaturefd LLC now owns 1,160 shares of the company’s stock worth $36,000 after buying an additional 378 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. lifted its holdings in shares of Celsius by 353.1% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 648 shares of the company’s stock worth $37,000 after buying an additional 505 shares in the last quarter. Institutional investors own 60.95% of the company’s stock.

Celsius Company Profile

(Get Free Report)

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

Featured Stories

Earnings History and Estimates for Celsius (NASDAQ:CELH)

Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.